Compass Therapeutics to Participate in Upcoming December Investor Events
Compass Therapeutics to Participate in Upcoming December Investor Events GlobeNewswire November 25, 2025 BOSTON, Nov. 25, 2025 (GLOBE NEWSWIRE) — Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics, today announced that the Company will participate in the following investor events during the month of December. Details are as follows: […]